Evidence map›Paper›PMID 18209095›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.

Thomas J Scriba, Barbara Kalsdorf, Deborah-Ann Abrahams, Fatima Isaacs, Jessica Hofmeister, Gillian Black, Hisham Y Hassan, Robert J Wilkinson, Gerhard Walzl, Sebastian J Gelderbloem and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 215 papers.

0numbers the graph read from it
0cells of the map it votes in
215citing papers in PubMed
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

215 citing papers in PubMed, 404 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2015
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Immunometabolic reprogramming ofFrontiers in tuberculosis · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

155 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 6 countries.

Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Observatory, South Africa. thomas.scriba@uct.ac.za
Barbara Kalsdorf
Deborah-Ann Abrahams
Fatima Isaacs
Jessica Hofmeister
Gillian Black
Hisham Y Hassan
Robert J Wilkinson
Gerhard Walzl
Sebastian J Gelderbloem
Hassan Mahomed
Gregory D Hussey
Willem A Hanekom
TuBerculosis Vaccine Initiative · NLSouth African Tuberculosis Vaccine Initiative · ZAStellenbosch University · ZAResearch Center Borstel - Leibniz Lung Center · DEUniversity College London · GBUniversity of Cape Town · ZAUniversity of Khartoum · SD

Funding

Protective immunity induced by newborn BCG vaccinationR01AI065653 · NIAID · UNIVERSITY OF CAPE TOWN · PI HANEKOM, WILLEM ALBERT · 2005 to 2009
$2.5M
The South African Infectious Disease Clinical Research Training ProgramD43TW007115 · FIC · UNIVERSITY OF CAPE TOWN · PI HUSSEY, GREGORY D · 2004 to 2011
$888k
FIC NIH HHS D43 TW007115FIC NIH HHS D43TW007115Medical Research Council MC_U117588499Medical Research Council U117588499(88499)NIAID NIH HHS N01 AI070022NIAID NIH HHS R01 AI065653NIAID NIH HHS R01AI065653Wellcome Trust 072070Wellcome Trust 080929Wellcome Trust 080929/Z/06/Z
6 · The paper itself

Abstract

We investigated whether the proinflammatory T cell cytokines IL-17 and IL-22 are induced by human mycobacterial infection. Remarkably, >20% of specific cytokine-producing CD4(+) T cells in peripheral blood of healthy, mycobacteria-exposed adults expressed IL-17 or IL-22. Specific IL-17- and IL-22-producing CD4(+) T cells were distinct from each other and from Th1 cytokine-producing cells. These cells had phenotypic characteristics of long-lived central memory cells. In patients with tuberculosis disease, peripheral blood frequencies of these cells were reduced, whereas bronchoalveolar lavage fluid contained higher levels of IL-22 protein compared with healthy controls. IL-17 was not detected in this fluid, which may be due to suppression by Th1 cytokines, as PBMC IL-17 production was inhibited by IFN-gamma in vitro. However, Th1 cytokines had no effect on IL-22 production in vitro. Our results imply that the magnitude and complexity of the anti-mycobacterial immune response have historically been underestimated. IL-17- and IL-22-producing CD4(+) T cells may play important roles in the human immune response to mycobacteria.

Indexed as

Bronchoalveolar Lavage FluidCD4-Positive T-LymphocytesFemaleHumansImmunologic MemoryInterleukin-17Interleukin-22InterleukinsMaleMycobacterium tuberculosisTh1 CellsT-Lymphocyte SubsetsTuberculosis, PulmonaryInterleukin-17Interleukin-22Interleukins

Identifiers

PMID18209095
PMCPMC2219462
OpenAlexW1646851899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.